An 18-year follow-up study discovered that elevated levels of FCN3 in circulation were associated with a higher incidence of micro- or macroalbuminuria in patients newly diagnosed with type 1 diabetes (66). This evidence concerns the gene FCN3 and type 1 diabetes mellitus.